NEW YORK (
CHANGE IN RATINGS
downgraded at Wells to Market Perform, Wells Fargo said. Valuation call. Estimates also cut, to match the company's new guidance.
Automatic Data Processing downgraded at Citigroup to Neutral from Buy, Citigroup said. $60 price target. Valuation call.
AdCare Health Systems
upgraded to hold at TheStreet Rating.
downgraded at UBS to Neutral from Buy, UBS said. $36 price target. Recent strong share performance and slower expected earnings growth.
( CBE) downgraded at UBS to Neutral from Buy, UBS said. $62 price target. Limited upside folliwing a strong run up.
downgraded at JP Morgan from Neutral to Underweight, JP Morgan said. Company lacks near-term catalysts.
downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $46 price target. Demand trends are unstable and the company is facing higher operating costs.
Delta Air Lines
upgraded at Evercore from Underweight to Equal-weight, Evercore Partners said. $11 price target. Company is seeing better sales trends.
upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $76 price target. Company boosted its guidance.
Dr. Pepper Snapple
upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $41 price target. Commodity prices are declining.
upgraded at Jefferies to Hold from Underperform, Jefferies said. $59.50 price target. Upgrade based on valuation.
downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Estimates also cut, given a lower net interest margin and reduced trading activity. $9 price target.
downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Solid quarter but it doesn't get any easier.
General Dynamics downgraded at Standpoint from Buy to Hold, Standpoint Research said. Valuation call, as the stock is up 30% since October.
upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $49 price target. Company is seeing consistent sales and cutting costs.
downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. $12 price target. SCP prices are declining.
Green Mountain Coffee
rated new Perform at Williams. Valuation call, based on a $50 price target.
downgraded at Stifel from Buy to Hold,
downgraded at Auriga from Buy to Hold. $28 price target. Industry still faces macro headwinds.
downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $62 price target. Company has a very aggressive spending program in 2012.
downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.
upgraded at Baird to Outperform, Robert Baird said. $60 price target. Stock likely to trade above Roche's hostile bid.
Illinois Tool Works
upgraded at BofA/Merrill from Underperform to Buy, Bank of America/Merrill Lynch said. $64 price target. Company is cutting costs and deserves a higher price multiple.
upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. Valuation call, based on a $20 price target.
upgraded at Leerink from Market Perform to Outperform, Leerink Swann said. Nextgen sequencing is an attractive growth area.
upgraded at Citigroup to Buy from Neutral, Citigroup said. $130 price target. Strong quarter and positive guidance.
downgraded at Jefferies to Hold from Buy, Jefferies said. $58.50 price target. Lower assumed processing and gathering volumes at Enogex.
downgraded at Goldman to Sell. $18 price target. Pricing trends are better in the commercial lines.
rated new Neutral at Goldman. $22 price target. Company has limited earnings upside potential.
downgraded at JP Morgan to Neutral. Estimates also cut, given a lower net interest margin and a difficult sales environment.
upgraded at Canaccord from Hold to Buy. $50 price target. Guidance will likely prove to be conservative.
downgraded at Goldman from Neutral to Sell. $25 price target. Company is leveraged to weaker financial services and European demand.
downgraded at KBW to Underperform, Keefe, Bruyette & Woods said. Valuation call, based on a $21 price target. Estimates also cut.
upgraded at Earlybird to Buy, Earlybird Capital said. $30 price target. End-market demand is improving and the company has operating leverage.
downgraded at Piper from Overweight to Neutral, Piper Jaffray said. Valuation call, based on a $54 price target.
downgraded at Jefferies to Hold from Buy, Jefferies said. $72 price target. Company miss will decrease target multiple.
STOCK COMMENTS / EPS CHANGES
estimates lowered at Citigroup through 2013, Citigroup said. Outlook for defense business is not as robust as originally forecast. Maintain Buy rating and $87 price target.
numbers lowered at Goldman. Shares of BTU now seen reaching $41, according to Goldman Sachs. Estimates also cut, given higher spending on Macarthur. Neutral rating.
Delta Air Lines
numbers raised at UBS. Shares of DAL now seen reaching $15. Estimates also increased on strong outlook. Buy rating.
estimates, target upped at Credit Suisse. DOV estimates were boosted through 2013, Credit Suisse said. Booking are stabilizing. Neutral rating and new $67 price target.
numbers cut at UBS. Shares of GLW now seen reaching $15, according to UBS. Estimates also lowered as near term catalysts remain elusive and fundamentals remain difficult. Buy rating.
numbers boosted at Goldman.Shares of GWW now seen reaching $211, Goldman Sachs said. Estimates also upped, Revenue growth is accelerating. Neutral rating.
estimates, target reduced at Goldman. HES estimates were cut through 2015, Goldman Sachs said. Company is facing higher costs. Neutral rating and new $66 price target.
Hess estimates, target lowered at UBS.Shares of HES now seen reaching $68, according to UBS. Estimates also lowered on 4Q miss and disappointing guidance. Buy rating.
target raised at UBS to $55 following Roche's hostile bid, UBS said. Maintain Neutral rating.
estimates, target raised at BMO. Shares of MCD now seen reaching $110, according to BMO Capital. Estimates also increased, given solid comp sales momentum. Market Perform rating.
estimates, target cut at Goldman. Shares of MOLX now seen reaching $24.50, according to Goldman Sachs. Estimates also reduced, as the company is realizing lower margins. Neutral rating.
numbers raised at Oppenheimer. Shares of NFLX now seen reaching $130, Oppenheimer said. Estimates also raised on better than expected results. Outperform rating.
numbers adjusted at UBS. Shares of OXY now seen reaching $114, according to UBS. Estimates lowered on higher production and DD&A expenses. Buy rating.
estimates, target lowered at UBS.Shares of SNDK now seen reaching $60, according to UBS. Estimates also lowered on soft near term demand. Buy rating.
numbers increased at Goldman. STJ estimates were raised through 2015, Goldman Sachs said. Company is seeing higher sales and keeping a tight lid on costs. Neutral rating and new $40 price target.
numbers raised at Goldman.Shares of STLD now seen reaching $18, according to Goldman Sachs. Estimates also increased, as the company is expanding margins. Neutral rating.
estimates lowered at Citigroup lowered through 2013, Citigroup said. Company missed consensus and guided down. Maintain $43 price target and Buy rating.
numbers boosted at Morgan Stanley. Shares of TWX now seen reaching $41, according to Morgan Stanley. Estimates also upped, as the company is buying back stock. Equal-weight.
estimates, target upped at Goldman. TXT estimates were boosted through 2014, Goldman Sachs said. Bell is driving growth and margins are expanding. Buy rating and new $31 price target.
numbers raised at Oppenheimer. Shares of URI now seen reaching $44, Oppenheimer said. Estimates also raised on impressive quarter and robust guidance. Outperform rating.
estimates, target cut at Goldman. Shares of WLP now seen reaching $76, according to Goldman Sachs. Estimates also reduced, as the company is investing more in infrastructure. Neutral rating.
estimates, target reduced at Credit Suisse. Shares of XRX now seen reaching $9, according to Credit Suisse. Estimates also cut, to match the company's new guidance.
>To submit a news tip, email:
and become a fan on
This article was written by a staff member of TheStreet.